SonoScape Medical

SonoScape Medical EBIT per Share

The EBIT per Share of SonoScape Medical (300633.SZ) as of Oct 17, 2026 is 0.43 CNY. In the previous year, EBIT per Share was 0.28 CNY — a change of 52.68% (higher).

EBIT per Share

0.43CNY

YoY

52.68%

Last updated:

EBIT per Share of SonoScape Medical is 2025 0.43 CNY. EBIT per Share of SonoScape Medical was 2024 0.28 CNY. It decreases by 52.68% higher compared to the previous year.

The SonoScape Medical EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2024
0.28 CNY
Jan 1, 2025
0.43 CNY
Jan 1, 2026 (e)
0.81 CNY
Jan 1, 2027 (e)
1.13 CNY
Jan 1, 2028 (e)
1.56 CNY
Jan 1, 2029 (e)
0.00 CNY
Jan 1, 2030 (e)
0.00 CNY
Jan 1, 2031 (e)
0.00 CNY
The SonoScape Medical EBIT per Share history
YEAREBIT per ShareYoY
est0.00CNY—
est0.00CNY—
est0.00CNY-100.00%
est1.56CNY+37.35%
est1.13CNY+39.20%
est0.81CNY+89.55%
0.43CNY+52.68%
0.28CNY-74.17%
1.09CNY+24.23%
0.88CNY+62.07%
0.54CNY+46.36%
0.37CNY+54.05%
0.24CNY-64.62%
0.68CNY+26.54%
0.54CNY+144.95%
0.22CNY+29.44%
0.17CNY-39.51%
0.28CNY+107.93%
0.13CNY-54.68%
0.30CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SonoScape Medical Stock analysis

What does SonoScape Medical do? SonoScape Medical Corp is a company based in Shenzhen, China, operating within the Health Care sector. It focuses on the research and development, production, and sales of medical diagnostic equipment. The company has a workforce of 2,334 employees. SonoScape Medical Corp completed its initial public offering (IPO) on April 6, 2017. Its primary products include medical ultrasound diagnostic equipment, such as color Doppler ultrasound systems and B-type ultrasound devices, as well as medical electronic endoscopes and related consumables, and blood analyzers. The company's headquarters are located in Shenzhen, Guangdong, and it maintains a corporate website at https://www.sonoscape.com/. SonoScape Medical Corp operates in the health care industry, providing diagnostic tools used in medical settings for patient assessment and treatment planning. The company's product portfolio emphasizes ultrasound technology, endoscopy, and laboratory equipment for blood analysis. It serves healthcare providers and facilities globally, though specific market details are not provided. The company's operations are centered around the development and commercialization of diagnostic solutions for the medical field. SonoScape Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SonoScape Medical stock

EBIT per Share of SonoScape Medical is 0.43 CNY in 2025.

EBIT per Share of SonoScape Medical changed from 0.28 CNY to 0.43 CNY, representing a 52.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share SonoScape Medical since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — SonoScape Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — SonoScape Medical